APIXORA
LIVE

Products available for live matching

Search API, API Intermediate, and Excipient products currently available for matching on APIXORA. If an item is not listed, leave a sourcing request.

API

1,910products

API Intermediate

736products

Excipient

42products

Product name A-Z
Product nameCAS No.
Orlistat 50%, 60%—
Orlistat IR Pellets96829-58-2
Orlistat Pellets96829-58-2
Orlistat Pellets 50%96829-58-2
Ormeloxifene78994-24-8
Ornidazole16773-42-5
Orphenadrine Citrate4682-36-4
Orphenadrine Hydrochloride341-69-5
Oseltamivir196618-13-0
Oseltamivir Phosphate204255-11-8
Osimertinib Mesylate1421373-66-1
Osmertinib (Osimertinib)1421373-65-0
Ospemifene128607-22-7
Oveporexton2460722-04-5
Oxacillin Sodium7240-38-2
Oxaliplatin61825-94-3
Oxandrolone53-39-4
Oxcarbazepine28721-07-5
Oxeladin Citrate52432-72-1
Oxeladin Pellets468-61-1
OXETACAINE126-27-2
OXFENDAZOLE53716-50-0
Oxiconazole Nitrate64211-46-7
Oxomemazine3689-50-7
Oxybutynin HCl1207344-05-5
OXYCLOZANIDE2277-92-1
Oxymetazoline Hydrochloride2315-02-08
Oxymetholone434-07-1
Ozagrel sodium189224-26-8
Ozanimod1306760-87-1
Ozenoxacin245765-41-7
Paclitaxel33069-62-4
Paclitaxel Hydrochloride33069-62-4
Palazestrant2092925-89-6
Palbociclib571190-30-2
Paliperidone144598-75-4
Paliperidone Palmitate199739-10-1
Palmitoyl Ethanolamide544-31-0
Paltusotine1610943-06-0
Pamabrom606-04-2
Pamidronate Disodium57248-88-1
Pancreatin 60%, 75%—
Pancreatin EC Pellets8049-47-6
Panipenem87726-17-8
Pantoprazole 14.29% EC & Domperidone 10.71%—
Pantoprazole 22%, 15%, 8.5%, 14%, 15%, 20%, 22.5%—
Pantoprazole EC + Domperidone SR Pellets102625-70-7 / 57808-66-9
Pantoprazole EC Pellets102625-70-7
Pantoprazole Pellets102625-70-7
Pantoprazole Sodium138786-67-1 / 164579-32-2

Supplier names, prices, and detailed regulatory information are available after RFQ matching.

Better Connections. Stronger Partnerships. Built on Trust.

Connect. Source. Grow.

Join APIXORA and grow your API business in Korea.

Together, let's build the future of the global pharmaceutical industry.

Get started

Connecting Global Pharma Intelligence